Briefly, A498-ESRP1-Luc2 or A498-Luc2 cells were first injected subcutaneously into immunodeficient SCID mice (which possess higher tumorigenicity), leading to palpable tumor formation after approximately 4 weeks. Here, ESRP1 is linked to neoplasm.